Press "esc" to clear
Go to Advanced Search

Showing results

5160 of 5716
NuclearporesyellowandDNAblue.jpg
  • Embargo expired:
    9-Aug-2018 11:00 AM EDT

Article ID: 698482

Nuclear Gatekeeper Could Block Undruggable Prostate Cancer Targets

Thomas Jefferson University

Blocking nuclear gateways that traffic cancer-promoting molecules to nucleus, could offer a new way to target aggressive cancer.

Released:
2-Aug-2018 12:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
ShorterBoniniMolCellimageAug2018.jpg
  • Embargo expired:
    9-Aug-2018 11:00 AM EDT

Article ID: 698745

Drugs in Development for Cancer May Also Fight Brain Diseases, including ALS

Perelman School of Medicine at the University of Pennsylvania

A class of cancer drugs called PARP inhibitors could be useful for treating and preventing brain disorders, including ALS (Lou Gehrig’s disease) and some forms of frontotemporal degeneration, by halting the misplacement of specific proteins that affect nerve cells.

Released:
8-Aug-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698695

First FDA-Approved Study of Focused Ultrasound to Open Blood-Brain Barrier

University of Maryland Medical Center/School of Medicine

In the first such clinical trial in the United States, physician-scientists with the University of Maryland School of Medicine (UMSOM) are investigating the use of MRI-guided focused ultrasound to open the blood-brain barrier. The trial will be conducted with patients undergoing brain cancer surgery at the University of Maryland Medical Center (UMMC).

Released:
9-Aug-2018 9:45 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
ZhouLu351x234.jpg

Article ID: 698761

An Ancient Medicine Shows New Promise: Arsenic in Combination with an Existing Drug Could Combat Cancer

Beth Israel Deaconess Medical Center

Investigators have discovered that arsenic in combination with an existing leukemia drug work together to target a master cancer regulator. The team, led by researchers at the Cancer Center at Beth Israel Deaconess Medical Center, is hopeful that the discovery could lead to new treatment strategies for diverse types of cancer.

Released:
9-Aug-2018 9:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
NerveCells_shutterstock_360993305.jpg

Article ID: 698753

Discovery presents treatment hope for Alzheimer’s and other neurodegenerative diseases

University of South Australia

There is new hope for the treatment of Alzheimer’s and other neurological diseases following a ground-breaking discovery made by an Australian-Chinese research collaboration.

Released:
9-Aug-2018 1:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698744

Inaugural Class of the Michael Brown Penn-GSK Postdoctoral Fellowship Award Program Commence Unique Collaborative Training

Perelman School of Medicine at the University of Pennsylvania

Four Penn Medicine postdoctoral trainees have been awarded three-year fellowships through a newly established program, the Michael Brown Penn-GSK Postdoctoral Fellowship Award Program from the Perelman School of Medicine at the University of Pennsylvania, in partnership with GlaxoSmithKline.

Released:
8-Aug-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698742

This small molecule could hold the key to promising HIV treatments

Cornell University

New research provides details of how the structure of the HIV-1 virus is assembled, findings that offer potential new targets for treatment.

Released:
8-Aug-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites

Article ID: 698743

Penn Biomedical Graduate Studies Program Receives $2 Million Gift from the Blavatnik Family Foundation to Support Scientists in Training

Perelman School of Medicine at the University of Pennsylvania

The Perelman School of Medicine at the University of Pennsylvania has received a $2 million gift from the Blavatnik Family Foundation to establish the Blavatnik Family Fellowship in Biomedical Research in the Penn Biomedical Graduate Studies (BGS) program.

Released:
8-Aug-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    8-Aug-2018 4:00 PM EDT

Article ID: 698707

Mount Sinai Researchers Create RNA and DNA-Sequencing Platform to Match Broader Swath of Cancer Drugs to Patients With Few Options

Mount Sinai Health System

A comprehensive RNA and DNA sequencing platform benefits late-stage and drug-resistant multiple myeloma patients by determining which drugs would work best for them, according to results from a clinical trial published in JCO Precision Oncology in August.

Released:
8-Aug-2018 11:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
RNA-large.jpg
  • Embargo expired:
    8-Aug-2018 1:00 PM EDT

Article ID: 698603

Scientists Develop a Way to Monitor Cellular Decision Making

Harvard Medical School

Scientists have designed a way to monitor cellular decision making by measuring the rate of RNA change over time. RNA is the “interpreter” or “decoder” of genetic instructions that tell cells how much of which protein to make. The new method is an algorithm that quantifies changes in various RNA markers—the molecular footprints of a cell’s past and present and an indicator of its future, providing clues about what the cell is trying to become. The approach sets the stage for understanding cellular behavior during human development and may offer a way to rapidly monitor how cells respond to medications and other treatments.

Released:
6-Aug-2018 12:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

5160 of 5716





Chat now!